These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27836402)

  • 1. Design and synthesis of water soluble β-aminosulfone analogues of SCH 900229 as γ-secretase inhibitors.
    Wu WL; Burnett DA; Clader J; Greenlee WJ; Jiang Q; Hyde LA; Del Vecchio RA; Cohen-Williams ME; Song L; Lee J; Terracina G; Zhang Q; Nomeir A; Parker EM; Zhang L
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5836-5841. PubMed ID: 27836402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure activity relationship studies of tricyclic bispyran sulfone γ-secretase inhibitors.
    Wu WL; Asberom T; Bara T; Bennett C; Burnett DA; Clader J; Domalski M; Greenlee WJ; Josien H; McBriar M; Rajagopalan M; Vicarel M; Xu R; Hyde LA; Del Vecchio RA; Cohen-Williams ME; Song L; Lee J; Terracina G; Zhang Q; Nomeir A; Parker EM; Zhang L
    Bioorg Med Chem Lett; 2013 Feb; 23(3):844-9. PubMed ID: 23265892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-ring modification of SCH 900229 and related chromene sulfone γ-secretase inhibitors.
    Wu WL; Sasikumar TK; Domalski MS; Qiang L; Burnett DA; Clader J; Greenlee WJ; Chan TM; Lee J; Zhang L
    Bioorg Med Chem Lett; 2013 Feb; 23(3):850-3. PubMed ID: 23265902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl sulfones: a new class of gamma-secretase inhibitors.
    Teall M; Oakley P; Harrison T; Shaw D; Kay E; Elliott J; Gerhard U; Castro JL; Shearman M; Ball RG; Tsou NN
    Bioorg Med Chem Lett; 2005 May; 15(10):2685-8. PubMed ID: 15863342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE).
    Boy KM; Guernon JM; Shi J; Toyn JH; Meredith JE; Barten DM; Burton CR; Albright CF; Marcinkeviciene J; Good AC; Tebben AJ; Muckelbauer JK; Camac DM; Lentz KA; Bronson JJ; Olson RE; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6916-24. PubMed ID: 21782431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
    D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A
    Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
    Guo T; Gu H; Hobbs DW; Rokosz LL; Stauffer TM; Jacob B; Clader JW
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3010-3. PubMed ID: 17418571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetracyclic sulfones as potent gamma-secretase inhibitors: synthesis and structure-activity relationship studies.
    Sasikumar TK; Burnett DA; Asberom T; Wu WL; Bennett C; Cole D; Xu R; Greenlee WJ; Clader J; Zhang L; Hyde L
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3645-8. PubMed ID: 20471254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
    Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
    J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease drug development based on Computer-Aided Drug Design.
    Zeng H; Wu X
    Eur J Med Chem; 2016 Oct; 121():851-863. PubMed ID: 26415837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors.
    Zhao Z; Pissarnitski DA; Josien HB; Bara TA; Clader JW; Li H; McBriar MD; Rajagopalan M; Xu R; Terracina G; Hyde L; Song L; Zhang L; Parker EM; Osterman R; Buevich AV
    Eur J Med Chem; 2016 Nov; 124():36-48. PubMed ID: 27560281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γ-Secretase as a target for Alzheimer's disease.
    Wolfe MS
    Adv Pharmacol; 2012; 64():127-53. PubMed ID: 22840746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design.
    Butler CR; Brodney MA; Beck EM; Barreiro G; Nolan CE; Pan F; Vajdos F; Parris K; Varghese AH; Helal CJ; Lira R; Doran SD; Riddell DR; Buzon LM; Dutra JK; Martinez-Alsina LA; Ogilvie K; Murray JC; Young JM; Atchison K; Robshaw A; Gonzales C; Wang J; Zhang Y; O'Neill BT
    J Med Chem; 2015 Mar; 58(6):2678-702. PubMed ID: 25695670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of presenilin 1-selective γ-secretase inhibitors with reconstituted γ-secretase complexes.
    Lee J; Song L; Terracina G; Bara T; Josien H; Asberom T; Sasikumar TK; Burnett DA; Clader J; Parker EM; Zhang L
    Biochemistry; 2011 Jun; 50(22):4973-80. PubMed ID: 21528914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors.
    Thompson LA; Liauw AY; Ramanjulu MM; Kasireddy-Polam P; Mercer SE; Maduskuie TP; Glicksman M; Roach AH; Meredith JE; Liu RQ; Combs AP; Higaki JN; Cordell B; Seiffert D; Zaczek RC; Robertson DW; Olson RE
    Bioorg Med Chem Lett; 2006 May; 16(9):2357-63. PubMed ID: 16473009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and SAR study of tricyclic sulfones as γ-secretase inhibitors: C-6 and C-8 positions.
    Su J; Tang H; McKittrick BA; Xu R; Clader JW; Greenlee WJ; Hyde L; Zhang L
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3447-51. PubMed ID: 21515050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective.
    Peretto I; La Porta E
    Curr Top Med Chem; 2008; 8(1):38-46. PubMed ID: 18220931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of potent inhibitors of human beta-secretase. Part 1.
    Freskos JN; Fobian YM; Benson TE; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Moon JB; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G
    Bioorg Med Chem Lett; 2007 Jan; 17(1):73-7. PubMed ID: 17046251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors.
    Churcher I; Beher D; Best JD; Castro JL; Clarke EE; Gentry A; Harrison T; Hitzel L; Kay E; Kerrad S; Lewis HD; Morentin-Gutierrez P; Mortishire-Smith R; Oakley PJ; Reilly M; Shaw DE; Shearman MS; Teall MR; Williams S; Wrigley JD
    Bioorg Med Chem Lett; 2006 Jan; 16(2):280-4. PubMed ID: 16275079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.